Jasper Therapeutics Inc.-CW26JSPRWPreferred / convertible
13F holders, Q1 2024 (March 31)4holders
$0.18avg. 13F price*
At the end of Q1 2024, 4 institutions reported holding Jasper Therapeutics Inc.-CW26 (JSPRW) in their 13F filings. The largest holders were Cowen and Company, LLC ($382K), Walleye Capital LLC ($108K) and TENOR CAPITAL MANAGEMENT Co., L.P. ($46K).
- Company
- Jasper Therapeutics Inc.-CW26
- CUSIP
- 471871111
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q1 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 0 | $0 |
| Exits | 2 | $12K |
Ownership 4 holders
| Cowen and Company, LLC | — | Add +13.4% | 2,098,624 | $382K |
| Walleye Capital LLC | — | Reduce -14.2% | 596,014 | $108K |
| TENOR CAPITAL MANAGEMENT Co., L.P. | — | No change | 250,000 | $46K |
| Walleye Trading LLC | — | No change | 14,095 | $3K |
"% of holder's portfolio" is JSPRW's weight in each manager's 13F, not the share of Jasper Therapeutics Inc.-CW26 the manager owns.